Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The volar fibroblast–keratinocyte signaling pathway is a specialized paracrine communication system that determines the unique physiological characteristics of glabrous (non-hairy) skin found on the palms and soles (Yamaguchi et al., 2004, J Cell Sci). This pathway is primarily driven by the secretion of Dickkopf-1 (DKK1) by volar dermal fibroblasts, which acts as a potent antagonist of the Wnt/beta-catenin signaling pathway in overlying keratinocytes (Yamaguchi et al., 2008, Gene). The suppression of Wnt signaling in these keratinocytes induces the expression of volar-specific markers, such as Keratin 9 (KRT9), and results in a thickened stratum corneum and the absence of hair follicles (Rognoni et al., 2016, Exp Dermatol). Dysregulation of this signaling axis is implicated in various skin disorders, including palmoplantar keratodermas and the site-specific development of acral lentiginous melanoma (Choi et al., 2014, J Invest Dermatol). While not a single drug target, components of this pathway, particularly DKK1 and the Wnt signaling cascade, are being explored for therapeutic intervention in wound healing and oncology (DKN-01 clinical trials). This signaling network highlights the importance of mesenchymal-epithelial interactions in maintaining tissue-specific identity and homeostasis.
Modulation of the Wnt/beta-catenin pathway via DKK1 secretion from dermal fibroblasts to influence keratinocyte differentiation and regional skin identity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Volar fibroblast–keratinocyte signaling pathways.